Targeting the podocyte to treat glomerular kidney disease

Drug Discovery Today

Volumn 20, Issue 10, 2015, Pages 1228-1234

  Lal, Mark A ^a   Young, Kenneth W ^b   Andag, Uwe ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b EVOTEC AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; EVALUATION STUDY; GLOMERULAR FILTRATION BARRIER; GLOMERULOPATHY; HUMAN; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; NONHUMAN; PHENOTYPE; PODOCYTE; PREDICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; CHRONIC KIDNEY FAILURE; DRUG DESIGN; GLOMERULUS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DRUG DESIGN; HUMANS; KIDNEY GLOMERULUS; MOLECULAR TARGETED THERAPY; PODOCYTES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84944442033     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.06.003     Document Type: Review

References (58)

1. K.U. Eckardt, and et al. Evolving importance of kidney disease: from subspecialty to global health burden Lancet 382 2013 158 169
2. D. de Zeeuw, and et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL Kidney Int. 65 2004 2309 2320
3. I. Gashaw, and et al. What makes a good drug target? Drug Discov. Today 16 2011 1037 1043
4. K. Tryggvason, and et al. Hereditary proteinuria syndromes and mechanisms of proteinuria N. Engl. J. Med. 354 2006 1387 1401
5. H.J. Lambers Heerspink, and D. de Zeeuw Novel drugs and intervention strategies for the treatment of chronic kidney disease Br. J. Clin. Pharmacol. 76 2013 536 550
6. H. Pavenstadt, and et al. Cell biology of the glomerular podocyte Physiol. Rev. 83 2003 253 307
7. A.B. Fogo Causes and pathogenesis of focal segmental glomerulosclerosis Nat. Rev. Nephrol. 11 2014 76 87
8. R.C. Wiggins The spectrum of podocytopathies: a unifying view of glomerular diseases Kidney Int. 71 2007 1205 1214
9. B.L. Wharram, and et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene J. Am. Soc. Nephrol. 16 2005 2941 2952
10. M.E. Pagtalunan, and et al. Podocyte loss and progressive glomerular injury in type II diabetes J. Clin. Invest. 99 1997 342 348
11. P.W. Mathieson The podocyte as a target for therapies - new and old Nat. Rev. Nephrol. 8 2012 52 56
12. P.T. Brinkkoetter, and et al. The role of the podocyte in albumin filtration Nat. Rev. Nephrol. 9 2013 328 336
13. J. Reiser, and et al. Toward the development of podocyte-specific drugs Kidney Int. 77 2010 662 668
14. P. Fiorina, and et al. Role of podocyte B7-1 in diabetic nephropathy J. Am. Soc. Nephrol. 25 2014 1415 1429
15. J. Reiser, and et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome J. Clin. Invest. 113 2004 1390 1397
16. C.C. Yu, and et al. Abatacept in B7-1-positive proteinuric kidney disease N. Engl. J. Med. 369 2013 2416 2423
17. A. Benigni, and et al. Abatacept in B7-1-positive proteinuric kidney disease N. Engl. J. Med. 370 2014 1261 1263
18. W. Kriz Podocyte is the major culprit accounting for the progression of chronic renal disease Microsc. Res. Tech. 57 2002 189 195
19. W. Kriz, and et al. The podocyte's response to stress: the enigma of foot process effacement Am. J. Physiol. Renal. Physiol. 304 2013 F333 F347
20. G.I. Welsh, and M.A. Saleem The podocyte cytoskeleton - key to a functioning glomerulus in health and disease Nat. Rev. Nephrol. 8 2012 14 21
21. M.A. Lal, and K. Tryggvason Knocking out podocyte rho GTPases: and the winner is J. Am. Soc. Nephrol. 23 2012 1128 1129
22. F. Mouawad, and et al. Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function Can. J. Physiol. Pharmacol. 91 2013 773 782
23. S. Akilesh, and et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis J. Clin. Invest. 121 2011 4127 4137
24. K. Asanuma, and et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling Nat. Cell Biol. 8 2006 485 491
25. M.A. Lal, and et al. Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration J. Am. Soc. Nephrol. 26 2015 647 662
26. M. Boerries, and et al. Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks Kidney Int. 83 2013 1052 1064
27. E.W. Brunskill, and et al. Defining the molecular character of the developing and adult kidney podocyte PLoS ONE 6 2011 e24640
28. M. Takemoto, and et al. Large-scale identification of genes implicated in kidney glomerulus development and function EMBO J. 25 2006 1160 1174
29. K. Hasegawa, and et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes Nat. Med. 19 2013 1496 1504
30. K. Hayashi, and et al. KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria J. Clin. Invest. 124 2014 2523 2537
31. M.M. Rinschen, and et al. Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier J. Am. Soc. Nephrol. 25 2014 1509 1522
32. W. Ju, and et al. Defining cell-type specificity at the transcriptional level in human disease Genome Res. 23 2013 1862 1873
33. S.J. Shankland, and et al. Podocytes in culture: past, present, and future Kidney Int. 72 2007 26 36
34. M.A. Saleem, and et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression J. Am. Soc. Nephrol. 13 2002 630 638
35. H.W. Lee, and et al. A podocyte-based automated screening assay identifies protective small molecules J. Am. Soc. Nephrol. 2015 pii:ASN.2014090859
36. K. Korn, and E. Krausz Cell-based high-content screening of small-molecule libraries Curr. Opin. Chem. Biol. 11 2007 503 510
37. J. Paeng, and et al. Enhanced glycogen synthase kinase-3beta activity mediates podocyte apoptosis under diabetic conditions Apoptosis 19 2014 1678 1690
38. W. Xu, and et al. Glycogen synthase kinase 3beta orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion J. Biol. Chem. 290 2015 1348 1363
39. D. Brehmer, and et al. Cellular targets of gefitinib Cancer Res. 65 2005 379 382
40. M. Raida Drug target deconvolution by chemical proteomics Curr. Opin. Chem. Biol. 15 2011 570 575
41. G. Warsow, and et al. PodNet, a protein-protein interaction network of the podocyte Kidney Int. 84 2013 104 115
42. N. Endlich, and et al. Two-photon microscopy reveals stationary podocytes in living zebrafish larvae J. Am. Soc. Nephrol. 25 2014 681 686
43. M.J. Hackl, and et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags Nat. Med. 19 2013 1661 1666
44. A.D. Kistler, and et al. In vivo imaging of kidney glomeruli transplanted into the anterior chamber of the mouse eye Sci. Rep. 4 2014 3872
45. H. Weavers, and et al. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm Nature 457 2009 322 326
46. F. Zhang, and et al. An in vivo functional analysis system for renal gene discovery in Drosophila pericardial nephrocytes J. Am. Soc. Nephrol. 24 2013 191 197
47. L. Ebarasi, and et al. Zebrafish: a model system for the study of vertebrate renal development, function, and pathophysiology Curr. Opin. Nephrol. Hypertens. 20 2011 416 424
48. W. Zhou, and F. Hildebrandt Inducible podocyte injury and proteinuria in transgenic zebrafish J. Am. Soc. Nephrol. 23 2012 1039 1047
49. S.N. Bhatia, and D.E. Ingber Microfluidic organs-on-chips Nat. Biotechnol. 32 2014 760 772
50. D. Huh, and et al. Reconstituting organ-level lung functions on a chip Science 328 2010 1662 1668
51. J.J. Song, and et al. Regeneration and experimental orthotopic transplantation of a bioengineered kidney Nat. Med. 19 2013 646 651
52. S. Akilesh, and et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane Proc. Natl. Acad. Sci. U. S. A. 105 2008 967 972
53. W.C. Chiang, and et al. Establishment of protein delivery systems targeting podocytes PLoS ONE 5 2010 e11837
54. P.V. Hauser, and et al. Novel siRNA delivery system to target podocytes in vivo PLoS ONE 5 2010 e9463
55. M.E. Dolman, and et al. Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells Adv. Drug Deliv. Rev. 62 2010 1344 1357
56. H.Y. Lan, and et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model J. Am. Soc. Nephrol. 14 2003 1535 1548
57. L. Huang, and et al. AKI after conditional and kidney-specific knockdown of stanniocalcin-1 J. Am. Soc. Nephrol. 25 2014 2303 2315
58. B. Fernandez-Fernandez, and et al. Therapeutic approaches to diabetic nephropathy - beyond the RAS Nat. Rev. Nephrol. 10 2014 325 346